E-Scopics

E-Scopics S.A.S is a MedTech company headquartered in France and founded in 2018. The company advances accessibility, affordability and ease of use of premium and quantitative ultrasound tools at the point of care. It has dematerialized ultrasound imaging technologies to create an agile and premium software ultrasound platform. Ultrasound-as-a-Service products derived from this platform are specific Apps commercialized with pay-per-use or subscription business models. The company's first product, Hepatoscope, leverages quantitative imaging capabilities to help assess non-invasively liver fibrosis and steatosis. It targets the non-invasive assessment of chronic liver diseases and especially MASLD-MASH at the bedside.